An excessive increase of C-reactive protein (CRP), IL-6, and ferritin observed in COVID-19 cases was termed CRS in analogy to similar findings in hemophagocytic lymphohistiocytosis and CAR-T cell therapy. This evidence concerns the gene CRP and hemophagocytic syndrome.